HMGB2 and endometrial cancer: To investigate the impact of HMGB2 knockdown on cancer cell proliferation, CCK-8 and EdU fluorescence staining assays were performed in eight cancer cell lines representing breast, cervical, ovarian, and endometrial cancers.